ArticleCureus2025
Clinical Characteristics, Etiologies, and Management Outcomes of Antenatal Hydronephrosis: A Prospective Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fetal Hydronephrosis: A Narrative Review of Diagnostic Pathways, Prognostic Markers, and Management.Cureus · 2026Review
- Accessory renal arteries in prenatal hydronephrosis as a pathophysiologic contributor or incidental vascular finding: a prospective observational study.BMC pregnancy and childbirth · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Hydronephrosis detected during prenatal imaging is among the more frequently encountered fetal renal findings. Although many cases resolve without intervention, some may signify underlying structural abnormalities of the urinary tract that warrant closer evaluation and possible treatment. This study aimed to assess the clinical patterns, causes, and outcomes of postnatal management in neonates and infants diagnosed prenatally with hydronephrosis. Methods A prospective observational study was conducted involving 50 neonates and infants with prenatal evidence of hydronephrosis. Initial postnatal ultrasonography was performed within the first few weeks of life, and additional investigations - such as micturating cystourethrograms and radionuclide scans - were undertaken selectively. Parameters recorded included gender, gestational age at detection, laterality, severity based on ultrasonographic grading, final diagnosis, and management approach. Hydronephrosis was categorized as mild, moderate, or severe. Statistical analysis was used to evaluate the association between the severity and the chosen treatment pathway. Results There was a higher number of male infants in the study group. Most cases were identified during mid-trimester anomaly scans. Involvement was equally distributed between right-sided and bilateral hydronephrosis, with fewer left-sided cases. Over half of the cases were mild, with fewer instances classified as moderate or severe. The most frequent underlying conditions included obstructive and reflux-related pathologies. Conservative observation proved effective in the majority of cases, especially in those with less severe involvement, whereas a minority with severe hydronephrosis required surgical correction. A significant correlation was noted between the degree of hydronephrosis and the need for operative intervention. Conclusion Prenatally identified hydronephrosis includes a range of potential causes that require a structured postnatal diagnostic approach. The severity seen on early imaging is a reliable indicator of likely management needs. Timely evaluation and appropriate monitoring enable effective differentiation between cases that will self-resolve and those requiring surgical care, supporting both clinical decision-making and parental guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.